Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearching for Mounjaro special offers is understandable — this is a prescription medicine with a significant monthly cost, and nobody wants to pay more than they have to. The honest answer, though, is that legitimate UK pharmacies do not run discounts, voucher codes or promotional offers on Mounjaro, and any seller who claims otherwise is worth treating with real caution. Mounjaro (tirzepatide) is a Prescription-Only Medicine in the UK, which means it can only be supplied following a clinical assessment by a qualified prescriber. That legal and clinical framework shapes everything about how it can be sold — including the fact that promotional pricing on the medicine itself falls outside what regulated pharmacies do. What does vary between providers is what you actually get for your money, and understanding that difference is worth a few minutes of your time.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
UK law (the Human Medicines Regulations 2012) prohibits advertising Prescription-Only Medicines to the public, and the MHRA is explicit that GLP-1 medicines are not assessed for quick or cosmetic weight loss. That regulatory frame rules out the kind of promotional marketing you'd see for supplements or gym memberships. No legitimate, GPhC-registered UK pharmacy runs discount codes, seasonal sales or voucher schemes on Mounjaro, not because they haven't thought of it, but because doing so would put their registration at risk.
This matters practically. When you see a social-media post, an influencer code or a website offering Mounjaro at a heavily discounted price, the question to ask is not whether it looks convincing, it's whether the seller appears on the GPhC pharmacy register. If they don't, the product they're selling has not passed through the licensed UK supply chain. The MHRA has warned publicly and repeatedly about fake weight-loss pens: a Northampton site producing counterfeit tirzepatide was raided in October 2025, and roughly 20 million doses of illegally traded weight-loss medicines (around £45 million street value) were seized across 2025 enforcement actions. Cheap is not a bargain when the contents of the pen are unknown.
So the first step when evaluating any Mounjaro provider isn't the price, it's verifying the pharmacy. You can do that in about thirty seconds on the GPhC register linked above.
Eli Lilly raised Mounjaro's UK list price from 1 September 2025. The highest-dose pen's list price moved from around £122 to around £330, a change that pushed private market prices upward across providers. Reported private prices since then have ranged roughly £149 to £375 per month, varying by dose and what the provider bundles in. That context is worth keeping in mind when comparing quotes, because headline prices from different services often cover very different things.
Some providers charge separately for the initial consultation, the prescription itself, delivery and any follow-up clinical support. Others roll everything into one figure. A lower headline number can therefore mean a higher real cost once those extras are added, or it can mean less clinical oversight. Our breakdown of what Mounjaro pricing in the UK actually covers walks through the components worth checking before you commit to any provider.
One practical question to ask any provider: what happens if you have a concern between doses? Aftercare access varies enormously, and for a medicine with a GI-led side-effect profile, knowing there's a prescriber available seven days a week is not a small thing. If you want to see what current Mounjaro offers look like from registered providers, that page sets out what's genuinely available within the bounds of UK regulations. At nume, the price you see includes the consultation, the prescription, tracked next-working-day delivery and priority aftercare, no separate line items, no auto-renewal pulling from your account each month.
Even setting cost aside, Mounjaro is only suitable for some people, and a prescriber has to make that call. The licensed eligibility for private treatment is adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not guarantee a prescription; the prescriber reviews your full health picture, including any medicines you're already taking.
There's a useful summary of how tirzepatide works and what the clinical evidence shows on our tirzepatide overview page, including what the SURMOUNT-1 trial reported on average weight loss over 72 weeks. Understanding the clinical basis helps set realistic expectations, which is part of what a proper consultation is for. The NHS also publishes patient-level information on tirzepatide on the NHS website, covering what it is, how it works and what side effects to watch for.
If you're already on treatment elsewhere and wondering about what to take alongside Mounjaro to get the most from it, or you've had questions about hair changes some people notice during treatment, those are worth reading before your next clinical review. They're questions our prescribers hear regularly.
A legitimate Mounjaro prescription, dispensed through a GPhC-registered UK pharmacy sourcing through the authorised supply chain, arrives as a genuine Eli Lilly KwikPen) a pre-filled device containing four weekly doses. At nume, orders placed before 12pm on a working day and approved the same day are dispatched the same day; DPD delivers the following working day, and you'll get a tracking link so you know exactly when to expect the box. Plain, unbranded packaging. The pen itself goes in the fridge when it arrives.
That might sound like a mundane detail, but it's the thing that actually distinguishes a safe supply from an unsafe one. Counterfeit pens seized in UK enforcement operations have in some cases contained insulin rather than tirzepatide, a dangerous substitution. Knowing your pen came through a verified, refrigerated supply chain and arrived from a pharmacy whose GPhC number you can look up is worth more than any promotional saving.
If you'd like to explore whether Mounjaro is clinically appropriate for you, the right starting point is a proper consultation rather than a price comparison. You can read about the Mounjaro offer available through our service, including exactly what's included, before deciding whether to proceed. You can also check your eligibility and start a free consultation with our prescribers, reviewed the same day, no algorithm involved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.